We are live on
!
Find out more
QCM
Quantinno Capital Management Portfolio holdings
AUM
$59.9B
1-Year Est. Return
28.07%
This Fund
S&P 500
This Quarter
Est. Return
+8.08%
1 Year Est. Return
+28.07%
3 Year Est. Return
+96.93%
5 Year Est. Return
+140%
10 Year Est. Return
–
AUM
$7.69B
AUM Growth
+$2.13B
(+38%)
Cap. Flow
+$1.69B
Cap. Flow
% of AUM
21.94%
Top 10 Holdings %
Top 10 Hldgs %
23.74%
Holding
1,500
New
186
Increased
1,112
Reduced
158
Closed
32
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$94.2M |
| 2 |
NVIDIA
NVDA
|
+$80.9M |
| 3 |
Microsoft
MSFT
|
+$77.5M |
| 4 |
Equity Lifestyle Properties
ELS
|
+$49.7M |
| 5 |
Amazon
AMZN
|
+$29.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$5.19M |
| 2 |
Humana
HUM
|
+$4.67M |
| 3 |
Nike
NKE
|
+$4.36M |
| 4 |
Dollar General
DG
|
+$3.25M |
| 5 |
Deere & Co
DE
|
+$3.23M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.84% |
| 2 | Financials | 12.57% |
| 3 | Healthcare | 10.61% |
| 4 | Consumer Discretionary | 10.22% |
| 5 | Industrials | 9.22% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Newmont
NEM
$96.2B
| $6.77M | 0.09% |
126,725
+10,888
| +9% | +$541K |
|
252
TransDigm Group
TDG
$70.7B
| $6.77M | 0.09% |
4,745
-314
| -6% | -$408K |
|
253
Southern Company
SO
$108B
| $6.77M | 0.09% |
75,083
+10,057
| +15% | +$859K |
|
254
Tenet Healthcare
THC
$22.2B
| $6.76M | 0.09% |
40,672
+11,749
| +41% | +$1.78M |
|
255
Genpact
G
$6.22B
| $6.74M | 0.09% |
171,825
+65,169
| +61% | +$2.36M |
|
256
American Water Works
AWK
$27B
| $6.71M | 0.09% |
45,915
+4,894
| +12% | +$694K |
|
257
Brown & Brown
BRO
$25.1B
| $6.67M | 0.09% |
64,387
+13,030
| +25% | +$1.3M |
|
258
EOG Resources
EOG
$77.7B
| $6.63M | 0.09% |
53,897
+11,219
| +26% | +$1.41M |
|
259
PayPal
PYPL
$50.3B
| $6.6M | 0.09% |
84,626
+7,016
| +9% | +$469K |
|
260
Hewlett Packard
HPE
$58.8B
| $6.59M | 0.09% |
322,274
+162,493
| +102% | +$3.11M |
|
261
Jazz Pharmaceuticals
JAZZ
$16.1B
| $6.56M | 0.09% |
58,913
+42,924
| +268% | +$4.7M |
|
262
Evergy
EVRG
$19.4B
| $6.54M | 0.09% |
105,489
+5,526
| +6% | +$322K |
|
263
Curtiss-Wright
CW
$25.1B
| $6.54M | 0.09% |
19,891
+1,722
| +9% | +$510K |
|
264
Intel
INTC
$413B
| $6.53M | 0.08% |
278,245
+206,609
| +288% | +$5.16M |
|
265
Freeport-McMoran
FCX
$86.2B
| $6.51M | 0.08% |
130,504
+16,166
| +14% | +$729K |
|
266
Northern Trust
NTRS
$21.8B
| $6.47M | 0.08% |
71,838
+14,617
| +26% | +$1.28M |
|
267
Capital One
COF
$128B
| $6.38M | 0.08% |
42,640
+17,881
| +72% | +$2.55M |
|
268
American International
AIG
$42.5B
| $6.36M | 0.08% |
86,888
+8,588
| +11% | +$640K |
|
269
CACI
CACI
$10.8B
| $6.36M | 0.08% |
12,604
+4,542
| +56% | +$2.1M |
|
270
Republic Services
RSG
$67.4B
| $6.31M | 0.08% |
31,400
+6,752
| +27% | +$1.36M |
|
271
AptarGroup
ATR
$8.69B
| $6.3M | 0.08% |
39,344
+7,997
| +26% | +$1.18M |
|
272
Intercontinental Exchange
ICE
$87.2B
| $6.19M | 0.08% |
38,541
+5,815
| +18% | +$897K |
|
273
Elevance Health
ELV
$81.5B
| $6.18M | 0.08% |
11,889
+2,461
| +26% | +$1.31M |
|
274
EPR Properties
EPR
$4.89B
| $6.18M | 0.08% |
126,026
+27,856
| +28% | +$1.27M |
|
275
Woodward
WWD
$23B
| $6.17M | 0.08% |
35,996
-4,321
| -11% | -$719K |
|
Similar funds
Quantinno Capital Management's Q3 2024 Portfolio in Review
As of Q3 2024, Quantinno Capital Management held 1,500 positions worth $7.69B, up 38% from $5.56B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Quantinno Capital Management deployed $1.69B of net new capital in Q3 2024, opening 186 new positions and adding to 1,112 existing holdings. Its largest new stake was Vanguard S&P 500 Growth ETF: 165,660 shares worth $9.53M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, down from 29% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Moderna, an estimated $5.19M trimmed.
- Quantinno Capital Management's largest Q3 2024 buy was Vanguard S&P 500 Growth ETF: 165,660 shares worth $9.53M.
- Quantinno Capital Management added most to Apple in Q3 2024, an estimated $94.2M increase.
- Quantinno Capital Management's biggest Q3 2024 reduction was Moderna, cutting an estimated $5.19M.
- Quantinno Capital Management fully exited Chemours in Q3 2024, selling an estimated $1.89M.
- Quantinno Capital Management's ten largest holdings make up 24% of its $7.69B portfolio in Q3 2024.
- Quantinno Capital Management opened 186 new positions and closed 32 in Q3 2024.
- Quantinno Capital Management's portfolio value rose 38% quarter-over-quarter to $7.69B.
Based on Quantinno Capital Management's 13F filing for Q3 2024, filed 14 Nov 2024.